Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma

Cancer

Volumn 77, Issue 9, 1996, Pages 1781-1786

  Aoyagi, Yutaka ^a   Oguro, Makoto ^a   Yanagi, Masahiko ^a   Mita, Yuhsuke ^b   Suda, Takeshi ^a   Suzuki, Yasufumi ^a   Hata, Kohjirou ^b   Ichii, Kichisaburoh ^b   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA CITY GENERAL HOSPITAL   (Japan)

Author keywords

alpha fetoprotein; des gamma carboxy prothrombin; hepatocellular carcinoma; recurrence; regression

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; DECARBOXYPROTHROMBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; EARLY DIAGNOSIS; FUCOSYLATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MONITORING; PRIORITY JOURNAL;

EID: 0029966485     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960501)77:9<1781::aid-cncr4>3.3.co;2-c     Document Type: Article

References (18)

1. Okuda K, and the Liver Cancer Group of Japan. Primary liver cancer in Japan. Cancer 1980;45:2663-9.
2. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res 1968;28:1344-50.
3. O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970;25:1091-8.
4. Nishi S, Hirai H. Radioimmunoassay of alpha-fetoprotein in hepatoma, other liver diseases and pregnancy. Gann Monogr 1973;14:79-87.
5. Liebman H, Furie BC, Tong MJ, Blanchard RA, Lo K-J, Lee S-D, et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-31.
6. Okuda H, Obata H, Nakanishi T, Furukawa R, Hashimoto E. Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma: a clinical and experimental study. J Hepatol 1987;4:357-63.
7. Fujiyama S, Morishita T, Hashiguchi O, Sato T. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
8. Hattori N, Ohmizo R, Unoura M, Tanaka N, Kobayashi K, and the PIVKA-II collaborative working group. J Tumor Marker Oncol 1988;3:207-16.
9. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:769-74.
10. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. 11th report (in Japanese). Kyoto: Shinkouinsatsu Co., Ltd., 1994.
11. Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Intern Med 1974;80:156-60.
12. Chen D-S, Sung J-L. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977;40:779-83.
13. Alpert E, Feller ER. Alpha-fetoprotein (AFP) in benign liver diseases. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978;74:856-8.
14. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, et al. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma. Lancet 1985;II:1353-4.
15. Aoyagi Y, Isemura M, Yosizawa Z, Suzuki Y, Sekine C, Ono T, et al. Fucosylation of serum alpha-fetoprotein with primary hepatocellular carcinoma. Biochim Biophys Acta 1985;830: 217-23.
16. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. The usefulness of the simultaneous determination of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 1991;67:2390-4.
17. Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro H, Yokota T, et al. Fucosylation index of alpha-fetoprotein: a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1993;17:50-2.
18. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br J Cancer 1993;67:486-92.